Delivery Devices at Lilly – Evolution and Future Trends

18 September 2023 17:55 - 18:25

  • Drug-Device integration and interactions
  • Container-Closure/Device interface
  • Tissue/Needle interface
  • Current challenges and potential pathways
  • High dose delivery
  • Large volume injections
  • Injection tolerability
  • Delivery/device preference
  • Concluding remarks and a look into the future
Drug delivery is a complex subject that requires the interdisciplinary engagement of various science and technology functions as well as the discipline of project management to effectively drive the development and commercialization of drug-device combination products to the market.

Andrew Ratz, Senior Vice President, Drug Delivery and Device Development, Eli Lilly and Company